Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04733274 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study completion date: Jul 1, 2024 to Dec 31, 2025v5
  2. Notable Primary endpoints revised (3)
    • Secondary endpoint revised
    • Publications: 2 to 3
    v4
  3. Minor Study completion date: Jun 1, 2022 to Jul 1, 2024
    • Publications: 1 to 2
    v3
  4. Minor Trial status: Recruiting to Active, Not Recruitingv2 Show 4 more changesShow less
    • Enrollment target: estimated 200 to confirmed 227
    • Primary completion date changed from estimate of Feb 28, 2026 to Jun 21, 2021
    • Study completion date: Feb 28, 2026 to Jun 1, 2022
    • Site details revised at 2 of 2 sites
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Technologic advances (i.e. next generation sequencing technologies and novel bioinformatics approaches) have been drivers of scientific discovery and have deepened our understanding of the genetics and genomics of health and disease. In parallel, the falling cost of sequencing has led to screening moving from specialty clinics into the primary care setting. However, our ability to help patients and families understand these technologies and related genetic health literacy issues lag behind. These factors pose a number of questions and challenges for clinicians including: how can we best present complex genetic/genomic information to patients to ensure that patients understand the information and can make informed decisions? What are the specific information and support needs of patients and families to be able to make decisions that are in line with their values? In collaboration with investigators from the Harvard Reproductive Endocrine Sciences Center at the Massachusetts General Hospital, this project broadly aims to examine patient understanding and factors affecting decisions surrounding genetic testing. Using the paradigm of a rare genetic disorder (isolated gonadotropin releasing hormone \[GnRH\] deficiency - hypogonadotropic hypogonadism/Kallmann syndrome \[HH/KS\]) we will examine the views and perspectives of patients and healthcare professionals alike regarding genetic/genomic information and testing with the intention of identifying patient-centered responses to these unmet needs and challenges.
Trial Details
NCT Number NCT04733274
Lead Sponsor Boston College
Collaborators: Massachusetts General Hospital
Conditions
(from sponsor)
Hypogonadism, Hypogonadotropic, Kallmann Syndrome
Related terms Hypogonadism, Kallmann Syndrome
Enrollment 227 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov